Taken together, these results confirm Mcl-1 as a crucial neutrophil survival factor, also under hyperlipidemic conditions, and demonstrate that Mcl-1 myeloid deletion can be used as a genetic tool to induce a long-lasting, severe neutropenia in atherosclerosis. Here, MCL1 is linked to Decreased total neutrophil count.